Clinical Trials for On Target Laboratories

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: On Target Laboratories

Clinical Trials (5)

NCT07124351
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
PHASE4Recruiting
15 participants
Started: Sep 5, 2025 · Completed: Sep 30, 2026
4 conditions2 sponsors1 location
NCT07039526
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
PHASE2Recruiting
50 participants
Started: Aug 19, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
PHASE2Recruiting
20 participants
Started: Apr 2, 2025 · Completed: Nov 30, 2025
2 conditions3 sponsors3 locations
NCT06511037
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
EARLY_PHASE1Recruiting
10 participants
Started: Nov 13, 2024 · Completed: Nov 30, 2026
2 conditions2 sponsors1 location
NCT06235125
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
PHASE1Recruiting
10 participants
Started: Apr 8, 2024 · Completed: Jan 20, 2026
5 conditions2 sponsors1 location